Navigation path

Community Register of medicinal products

Community register of veterinary medicinal products
AUTHORISED  

Product information
Invented name: Suvaxyn PCV   
Auth. number : EU/2/09/099
INN : Porcine circovirus recombinant virus (cpcv) 1-2, inactivated
ATC: QI - Immunologicals
QI09 - Immunologicals for suidae
QI09A - Pig
QI09AA - Inactivated viral vaccines
QI09AA07 - Porcine circovirus
(See WHO ATCvet Index)
Indication: Active immunisation of pigs over the age of 3 weeks against Porcine Circovirus type 2 (PCV2).
Marketing Authorisation Holder: Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

  EPAR and active package presentations

Package presentations

The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2009 Centralised - Authorisation EMEA/V/C/149 (2009)6045 of 24/07/2009
25/02/2010 Centralised - Variation EMEA/V/C/149/II/1
28/04/2010 Centralised - Variation -
01/10/2010 Centralised - Suspension of martketing authorisation EMEA/V/C/149/A-45/65 (2010)6747 of 27/09/2010
25/05/2011 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/149/T/4 (2011)3711 of 23/05/2011
23/07/2012 Centralised - Variation EMEA/V/C/149/IA/6
Updated with Decision(2012)7892 of 29/10/2012
12/10/2012 Centralised - Lift of suspension EMEA/V/C/149/Z/7 (2012)7205 of 10/10/2012
01/11/2012 Centralised - Variation - (2012)7892 of 29/10/2012